Summary
Formaldehyde and methylglyoxal are generated via deamination from methylamine and aminoacetone respectively catalyzed by semicarbazide-sensitive amine oxidase (SSAO). Malondialdehyde (MDA) and 4-hydroxynonenal (HNE) are end products of lipid peroxidation due to oxidative stress. These aldehydes are capable of inducing protein cross-linkage. Elevated levels of aldehydes were found in Alzheimer’s disease (AD). These reactive metabolites may potentially play important roles in β-amyloid (Aβ) aggregation related to the pathology of AD. In the present study thioflavin-T (ThT) fluorometry, an immuno-dot-blot assay and atomic force microscopy (AFM) were employed to reveal the effect of aldehydes on Aβ aggregation in vitro. The target on Aβ for interaction with formaldehyde was identified. The results support the involvement of endogenous aldehydes in amyloid deposition related to AD.
Similar content being viewed by others
References
F Boomsma PJ de Kam G Tjeerdsma et al. (2000) ArticleTitlePlasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure Eur Heart J 21 1859–1863 10.1053/euhj.2000.2176 Occurrence Handle10.1053/euhj.2000.2176 Occurrence Handle1:CAS:528:DC%2BD3cXos1Ogurw%3D Occurrence Handle11052858
F Coria F Prelli EM Castano et al. (1988) ArticleTitleBeta-protein deposition: a pathogenetic link between Alzheimer’s disease and cerebral amyloid angiopathies Brain Res 463 187–191 10.1016/0006-8993(88)90545-8 Occurrence Handle10.1016/0006-8993(88)90545-8 Occurrence Handle1:CAS:528:DyaL1MXjslelsA%3D%3D Occurrence Handle3058268
R Dei A Takeda H Niwa M Li Y Nakagomi M Watanabe T Inagaki Y Washimi Y Yasuda K Horie T Miyata G Sobue (2002) ArticleTitleLipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer’s disease Acta Neuropathol (Berl) 104 113–122 10.1007/s00401-002-0523-y Occurrence Handle10.1007/s00401-002-0523-y Occurrence Handle1:CAS:528:DC%2BD38XkvFKqsbw%3D
M del Mar Hernandez M Esteban P Szabo M Boada M Unzeta (2005) ArticleTitleHuman plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging Neurosci Lett 384 183–187 10.1016/j.neulet.2005.04.074 Occurrence Handle10.1016/j.neulet.2005.04.074 Occurrence Handle15894424 Occurrence Handle1:CAS:528:DC%2BD2MXlt1Kitb0%3D
M Dib C Garrel A Favier V Robin C Desnuelle (2002) ArticleTitleCan malondialdehyde be used as a biological marker of progression in neurodegenerative disease? J Neurol 249 367–374 10.1007/s004150200025 Occurrence Handle10.1007/s004150200025 Occurrence Handle1:CAS:528:DC%2BD38XksVGlsLg%3D Occurrence Handle11967639
I Ferrer JM Lizcano M Hernandez M Unzeta (2002) ArticleTitleOverexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer’s disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Neurosci Lett 321 21–24 10.1016/S0304-3940(01)02465-X Occurrence Handle10.1016/S0304-3940(01)02465-X Occurrence Handle1:CAS:528:DC%2BD38XhsFWgtLk%3D Occurrence Handle11872247
D Gubisne-Haberle W Hill M Kazachkov JS Richardson PH Yu (2004) ArticleTitleProtein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine J Pharmacol Exp Therap 310 1125–1132 10.1124/jpet.104.068601 Occurrence Handle10.1124/jpet.104.068601 Occurrence Handle1:CAS:528:DC%2BD2cXnt1eqtbc%3D
KA Jellinger (2002) ArticleTitleAlzheimer disease and cerebrovascular pathology: an update J Neural Trans 109 813–836 10.1007/s007020200068 Occurrence Handle10.1007/s007020200068 Occurrence Handle1:STN:280:DC%2BD38zmt1SitA%3D%3D
M Kawai RN Kalaria P Cras SL Siedlak ME Velasco ER Shelton HW Chan BD Greenberg G Perry (1993) ArticleTitleDegeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease Brain Res 623 142–146 10.1016/0006-8993(93)90021-E Occurrence Handle10.1016/0006-8993(93)90021-E Occurrence Handle1:CAS:528:DyaK3sXmt1egtLs%3D Occurrence Handle8221082
R Kayed E Head JL Thompson TM McIntire SC Milton CW Cotman CG Glabe (2003) ArticleTitleCommon structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 486–489 10.1126/science.1079469 Occurrence Handle10.1126/science.1079469 Occurrence Handle1:CAS:528:DC%2BD3sXivFyms7k%3D Occurrence Handle12702875
M Kazachkov PH Yu (2005) ArticleTitleA novel HPLC procedure for detection and quantification of aminoacetone, a precursor of methylglyoxal, in biological samples J Chromatogr B 824 116–112 Occurrence Handle10.1016/j.jchromb.2005.07.006 Occurrence Handle1:CAS:528:DC%2BD2MXpslynsb0%3D
WL Klein WB Stine SuffixJr DB Teplow (2004) ArticleTitleSmall assemblies of unmodified amyloid-protein are the proximate neurotoxin in Alzheimer’s disease Neurobiol Aging 25 569–580 10.1016/j.neurobiolaging.2004.02.010 Occurrence Handle10.1016/j.neurobiolaging.2004.02.010 Occurrence Handle1:CAS:528:DC%2BD2cXksVGgt7o%3D Occurrence Handle15172732
B Kuhla HJ Luth D Haferburg K Boeck T Arendt G Munch (2005) ArticleTitleMethylglyoxal, glyoxal, and their detoxification in Alzheimer’s disease Ann NY Acad Sci 1043 211–216 10.1196/annals.1333.026 Occurrence Handle10.1196/annals.1333.026 Occurrence Handle1:CAS:528:DC%2BD2MXpvVKqsb8%3D Occurrence Handle16037241
DT Loo A Copani CJ Pike ER Whittemore AJ Walencewizcz CW Cotman (1993) ArticleTitleApoptosis is induced by β-amyloid in cultured central nervous system neurons Proc Natl Acad Sci USA 90 7951–7955 10.1073/pnas.90.17.7951 Occurrence Handle10.1073/pnas.90.17.7951 Occurrence Handle1:CAS:528:DyaK3sXmtVWis7Y%3D Occurrence Handle8367446
JA Luchsinger MX Tang Y Stern S Shea R Mayeux (2001) ArticleTitleDiabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort Am J Epidemiol 154 635–641 10.1093/aje/154.7.635 Occurrence Handle10.1093/aje/154.7.635 Occurrence Handle1:STN:280:DC%2BD3MrjvVKnsA%3D%3D Occurrence Handle11581097
J Ma A Yee HB Brewer SuffixJr S Das H Potter (1994) ArticleTitleAmyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments Nature 372 92–94 10.1038/372092a0 Occurrence Handle10.1038/372092a0 Occurrence Handle1:CAS:528:DyaK2cXmvFygur0%3D Occurrence Handle7969426
LT McGrath BM McGleenon S Brennan D McColl S McILroy AP Passmore (2001) ArticleTitleIncreased oxidative stress in Alzheimer-disease as assessed with 4-hydroxynonenal but not malondialdehyde Q J Med 94 485–490 Occurrence Handle1:STN:280:DC%2BD3Mvos1agtw%3D%3D
C Messier (2003) ArticleTitleDiabetes, Alzheimer’s disease and apolipoprotein genotype Exp Gerontol 38 941–946 10.1016/S0531-5565(03)00153-0 Occurrence Handle10.1016/S0531-5565(03)00153-0 Occurrence Handle1:CAS:528:DC%2BD3sXmvVygtrs%3D Occurrence Handle12954480
AE Roher JD Lowenson S Clarke AS Woods RJ Cotter E Gowing MJ Ball (1993) ArticleTitlebeta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease Proc Natl Acad Sci USA 90 10836–10840 10.1073/pnas.90.22.10836 Occurrence Handle10.1073/pnas.90.22.10836 Occurrence Handle1:CAS:528:DyaK2cXltFOjtQ%3D%3D Occurrence Handle8248178
LM Sayre DA Zelasko PL Harris G Perry RG Salomon MA Smith (1997) ArticleTitle4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer’s disease J Neurochem 68 2092–2097 Occurrence Handle1:CAS:528:DyaK2sXivVSisbw%3D Occurrence Handle9109537 Occurrence Handle10.1046/j.1471-4159.1997.68052092.x
DJ Selkoe (2002) ArticleTitleAlzheimer’s disease: genes, protein and therapy Physiol Rev 81 741–766
L Stanyer DJ Betteridge CC Smith (2004) ArticleTitleExaggerated polymerisation of beta-amyloid 40 stimulated by plasma lipoproteins results in fibrillar Abeta preparations that are ineffective in promoting ADP-induced platelet aggregation Biochim Biophys Acta 1674 305–311 Occurrence Handle1:CAS:528:DC%2BD2cXpvVygur4%3D Occurrence Handle15541300
KV Subbarao JS Richardson LC Ang (1990) ArticleTitleAutopsy samples of Alzheimer’s cortex show increased peroxidation in vitro J Neurochem 55 342–345 10.1111/j.1471-4159.1990.tb08858.x Occurrence Handle10.1111/j.1471-4159.1990.tb08858.x Occurrence Handle1:CAS:528:DyaK3cXksFKrs78%3D Occurrence Handle2355227
PJ Thornalley (2002) ArticleTitleGlycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options Int Rev Neurobiol 50 37–57 10.1016/S0074-7742(02)50072-6 Occurrence Handle10.1016/S0074-7742(02)50072-6 Occurrence Handle1:CAS:528:DC%2BD38XotFaqur8%3D Occurrence Handle12198817
PH Yu YL Deng (1998) ArticleTitleEndogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: Involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover Atherosclerosis 140 357–363 10.1016/S0021-9150(98)00142-7 Occurrence Handle10.1016/S0021-9150(98)00142-7 Occurrence Handle1:CAS:528:DyaK1cXms1Srsbo%3D Occurrence Handle9862279
PH Yu S Wright EH Fan ZR Lun D Gubisne-Haberle (2003) ArticleTitlePhysiological and pathological implications of semicarbazide-sensitive amine oxidase Biochim Biophys Acta 1647 193–199 Occurrence Handle1:CAS:528:DC%2BD3sXislCisrY%3D Occurrence Handle12686132
PH Yu DM Zuo (1993) ArticleTitleOxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells; Possible consequence for diabetes Diabetes 42 594–603 10.2337/diabetes.42.4.594 Occurrence Handle10.2337/diabetes.42.4.594 Occurrence Handle1:CAS:528:DyaK3sXktVKhu7Y%3D Occurrence Handle8454111
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, K., Kazachkov, M. & Yu, P. Effect of aldehydes derived from oxidative deamination and oxidative stress on β-amyloid aggregation; pathological implications to Alzheimer’s disease. J Neural Transm 114, 835–839 (2007). https://doi.org/10.1007/s00702-007-0697-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-007-0697-5